secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tonix Pharmaceuticals Holding Corp. (TNXP)
CIK:        0001430306
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001387131-22-010938
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tonix receives Nasdaq deficiency notice for minimum bid price; 180-day cure period
--------------------------------------------------------------------------------

- Received Nasdaq notice on Oct 25, 2022 for non-compliance with minimum bid price $1 per share.
- Has until April 24, 2023 to regain compliance; bid price must close at $1+ for 10 consecutive days.
- If unmet, may seek additional 180-day period by meeting other listing standards and filing cure intent.
- Stock not immediately delisted; company monitoring price and evaluating options to cure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1430306/000138713122010938/0001387131-22-010938-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1430306/000138713122010938/tnxp-8k_102522.htm
  HTML page:      https://secwatch.observer/filing/0001387131-22-010938

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer